Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
LIPOXYGENASE PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
Document Type and Number:
WIPO Patent Application WO/2000/061765
Kind Code:
A2
Abstract:
The nucleotide and corresponding amino acid sequences are reported for a novel class of mammalian lipoxygenase proteins. The novel lipoxygenase encoding polynucleotides were obtained from human gene trap clones and human cDNA libraries.

Inventors:
TURNER C ALEXANDER JR
ZAMBROWICZ BRIAN
NEHLS MICHAEL
FRIEDRICH GLENN
SANDS ARTHUR T
Application Number:
PCT/US2000/009657
Publication Date:
October 19, 2000
Filing Date:
April 12, 2000
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
LEXICON GENETICS INC (US)
International Classes:
A01K67/027; C07K16/40; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N9/02; C12N15/09; C12N15/53; (IPC1-7): C12N15/53; C12N9/02; C07K16/40; A01K67/027
Domestic Patent References:
WO1999013111A11999-03-18
WO1994005777A11994-03-17
Foreign References:
EP0325773A11989-08-02
Other References:
BOEGLIN W. ET AL.: "A 12R-lipoxygenase in human skin: Mechanistic evidence, molecular cloning, and expression" PNAS U.S.A, vol. 95, 1998, pages 6744-6749, XP002143911
ROUZER C A ET AL: "CHARACTERIZATION OF CLONED HUMAN LEUKOCYTE 5 LIPOXYGENASE EXPRESSED IN MAMMALIAN CELLS" JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 263, no. 21, 1988, pages 10135-10140, XP002143912 ISSN: 0021-9258
BOADO R. ET AL.: "Differential expression of arachidonate 5-lipoxygenase transcripts in human brain tumors: evidence for the expression of a multitranscript family" PNAS U.S.A., vol. 89, 1992, pages 9044-9048, XP002143913
Attorney, Agent or Firm:
Garrett, Arthur S. (Henderson Farabow, Garrett & Dunner, L.L.P. 1300 I Stree, N.W. Washington DC, US)
Download PDF:
Claims:
WHAT IS CLAIMED IS:
1. An isolated polynucleotide selected from the group consisting of: (a) a polynucleotide comprising SEQ ID NOS: 1,3,5,7,9, 11,13, 15, 17, 19, 21, 23, 25, 27, or 29; (b) a polynucleotido cncoding a polypeptide comprising SEQ IDNOS2,4,6,8, 10, 12, 14, 16, 18, or28; and (c) a polynucleotide comprising a first polynucleotide capable of hybridizing to a second polynucleotide under highly stringent conditions, wherein said first polynucleotide encodes a naturally occurring polypeptide and wherein said second polynucleotide is complementary to SEQ ID NOS:1, 3, 5, 7,9,11,13,15,17,19,21,23,25,27, or 29.
2. An isolated oliganucleotide comprising from about 16 to about 40 bases of a polynucleotide of Claim 1.
3. An isolated polypeptide selected from the group consisting of : (a) a polypeptide comprising SEQ ID NOS: 2,4,6,8,10,12, 14, 16, 18, 20, 22, 24, 26, or 28; and (b) a polypeptide encoded by a polynucleotide of Claim 1.
4. An antibody specific to a polypeptide of Claim 3.
5. A cell engineered to contain a polynucleotide of Claim 1.
6. A transgenic mouse engineered to contain a polynucleotide of Claim 1.
Description:
INTERNATIONAL SEARCH REPORT PCT/US00/09657 C. (Continuation) DOCUMENTS CONSIDERED TO BE RELEVANT Category Citation of document, with indication, where appropriate, of the relevant passages Relevant to claim No. A WO 94 05777 A (HOPE CITY; NADLER JERRY L 1-6 (US) ; NATARAJAN RAMA DEVI (US); GU JIALI) 17 March 1994 (1994-03-17) the whole document A ROUZER C A ET AL:"CHARACTERIZATION OF 1-6 CLONED HUMAN LEUKOCYTE 5 LIPOXYGENASE EXPRESSED IN MAMMALIAN CELLS" JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 263, no. 21,1988, pages 10135-10140, XP002143912 ISSN:0021-9258 the whole document A BOADO R. ET AL. :"Differential expression 1-6 of arachidonate 5-lipoxygenase transcripts in human brain tumors: evidence for the expression of a multitranscript family" PNAS U. S. A., vol. 89, 1992, pages 9044-9048, XP002143913 the whole document 1 h rational application No. PCT/US 00/09657 INTERNATIONAL SEARCH REPORT Box I Observations where certain claims were found unsearchable (Continuation of item 1 of first sheet) This international Search Report has not been established in respect of certain claims under Article 17 (2) (a) for the following reasons: 1. Claims Nos. : because they relate to subject matter not required to be searched by this Authority, namely: 2. Claims Nos.: because they relate to parts of the International Application that do not comply with the prescribed requirements to such an extent that no meaningful International Search can be carried out, specifically: 3. j Claims Nos.: because they are dependent claims and are not drafted in accordance with the second and third sentences of Rule 6.4 (a). Box 11 Observations where unity of invention is lacking (Continuation of item 2 of first sheet) This international Searching Authority found multiple inventions in this international application, as follows: see additional sheet 1. As all required additional search fees were timely paid by the applicant, this International Search Report covers all searchable claims 2. As all searchable claims could be searched without effort justifying an additional fee, this Authority did not invite payment of any additional fee. 3. As only some of the required additional search fees were timely paid by the applicant, this International Search Report covers only those claims for which fees were paid, specifically claims Nos.: 4. No required additional search fees were timely paid by the applicant. Consequently, this International Search Report is restricted to the invention first mentioned in the claims ; it is covered by claims Nos.: Claims 1-6 partially. Remark on Protest The additional search fees were accompanied by the applicant's protest. u No protest accompanied the payment of additional search fees. u International Application No. PCT/US 00/09657 FURTHER INFORMATION CONTINUED FROM PCT/ISA/210 This International Searching Authority found multiple (groups of) inventions in this international application, as follows: 1. Claims: 1-6 partially An isolated polynucleotide selected from: a polynucleotide comprising SEQ ID NO : 1, encoding a polypeptide comprising SEQ ID NO : 2, and a polynucleotide hybridizing thereto under high stringent conditions. An isolated oligonucleotide comprising from about 16 to about 40 bases of said polynucleotide. An isolated polypeptide selected from: a polypeptide comprising SEQ ID NO : 2, and a polypeptide encoded by said polynucleotide. An antibody specific for said polypeptide. A cell and a transgenic mouse engineered to contain said polynucleotide. 2. Claims: 1-6 partially idem for SEQ ID NO : 3,4 3. Claims: 1-6 partially idem for SEQ ID NO : 5,6 4. Claims: 1-6 partially idem for SEQ ID NO : 7,8 5. Claims: 1-6 partially idem for SEQ ID NO : 9,10 6. Claims: 1-6 partially idem for SEQ ID NO : 11,12 7. Claims: 1-6 partially idem for SEQ ID NO : 13,14 8. Claims: 1-6 partially idem for SEQ ID NO : 15,16 9. Claims: 1-6 partially Intemational Application No. PCT/US 00/09657 FURTHER INFORMATION CONTINUED FROM PCT/ISA/210 idem for SEQ ID NO : 17,18 10. Claims: 1-6 partially idem for SEQ ID NO : 19,20 11. Claims: 1-6 partially idem for SEQ ID NO : 21,22 12. Claims: 1-6 partially idem for SEQ ID NO : 23,24 13. Claims: 1-6 partially idem for SEQ ID NO : 25,26 14. Claims: 1-6 partially idem for SEQ ID NO : 27,28 15. Claims: 1,2,5,6 An isolated polynucleotide selected from: a polynucleotide comprising SEQ ID NO : 29, and a polynucleotide hybridizing thereto under high stringent conditions. An isolated oligonucleotide comprising from about 16 to about 40 bases of said polynucleotide. A cell and a transgenic mouse engineered to contain said polynucleotide. INTERNATIONAL SEARCH REPORT tnterrnai Apptication No rmation on patent tamily members PC I/J S () (i 9 657 Patent document Publication Patent family Publication cited in search report date member (s) date WO 9913111 A 18-03-1999 EP 1012343 A 28-06-2000 EP 0325773 A 02-08-1989 JP 2000453 A 05-01-1990 WO 9405777 A 17-03-1994 AU 674339 B 19-12-1996 AU 4840393 A 29-03-1994 CA 2077461 A C1-03-1994 EP 0621895 A 02-11-1994 EP 0696193 A 14-02-1996 JP 75รป0254 T 12-C1-1995 WO 9518609 A 13-07-1995